-
In category NewsFVR grows its core capabilities in vaccine research
FVR – Finnish Vaccine Research Ltd, one of Europe’s leading commercial vaccine trial service providers, is growing its core competencies by hiring extensive industry and medical expertise. Santtu Heinonen appointedLead Medical ExpertMD, PhD, ORCID >> Santtu is a pediatrician, soon to finalize specialty in pediatric infectious diseases. He has more than 15 years of experience […]
-
In category Press releasesFinnish research expertise utilizing national register data produces internationally unique information
The results of pragmatic FinFluHD influenza trial conducted in Finland have been published in a peer-reviewed “Influenza and Other Respiratory Viruses” journal. The trial evaluated the effectiveness of the high-dose flu vaccine in people over 65 years of age. The goal of the FinFluHD trial was to find out whether a high-dose vaccine containing four […]
-
In category NewsStudying vaccines for CMV (cytomegalovirus)
FVR – Finnish Vaccine Research has a team of specialists who have conducted two major clinical studies of CMV vaccines over several years, enrolling healthy women under 40 years of age. Our track-record of enrolling participants for these studies is good, despite screening criteria that limit the number of qualified participants, such as contact with […]
-
In category NewsWhy partner with FVR – Finnish Vaccine Research in studying vaccines for RSV?
FVR’s unique network of ten clinical vaccine research clinics ensures good capacity and flexibility is available for conducting a successful study. Our expertise covers comprehensive clinical vaccine trials through phases 1-4, including register-based Real-World Evidence studies and large-scale pragmatic field trials, conducted together with healthcare providers. Finland offers an excellent setting for a successful study […]